| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.7M+17.0% | $4.0M+67.0% | $2.4M-95.2% | $50.0M | — |
| Cost of revenue (excluding amortization and depreciation) | $47.5M+42.6% | $33.3M+27.8% | $26.1M+401.4% | $5.2M | — |
| Research and development | $183.3M-2.0% | $187.1M+91.0% | $97.9M+69.0% | $57.9M-0.2% | $58.1M |
| Selling, general and administrative | $570.6M+38.7% | $411.4M+27.3% | $323.1M+102.9% | $159.3M+139.0% | $66.6M |
| Loss (Gain) in fair value of contingent consideration | -$2.5M-108.8% | $28.1M-42.5% | $48.9M+1383.3% | $3.3M | — |
| Intangible asset amortization | $6.4M-0.3% | $6.4M+0.3% | $6.4M+54.0% | $4.1M | — |
| Total operating expenses | $805.3M+20.9% | $666.3M+32.6% | $502.4M+118.6% | $229.8M+84.3% | $124.7M |
| Loss from operations | -$166.8M+40.6% | -$280.6M-21.0% | -$231.8M-28.9% | -$179.8M-44.2% | -$124.7M |
| Interest expense, net | -$6.6M+0.2% | -$6.6M-1.8% | -$6.5M+12.0% | -$7.3M-28.8% | -$5.7M |
| Loss on debt extinguishment | -$10.4M | — | — | — | — |
| Loss before income taxes | -$183.7M+36.0% | -$287.1M-20.5% | -$238.3M-27.3% | -$187.1M-43.5% | -$130.4M |
| Income tax benefit (expense) | $530K+723.5% | -$85K+91.1% | -$960K | — | — |
| Net loss | -$183.2M+36.2% | -$287.2M-20.1% | -$239.2M-27.8% | -$187.1M-43.5% | -$130.4M |
| Net loss per common share, basic | -$3680.00+38.6% | -$5990.00-13.7% | -$5270.00-14.6% | -$4600.00-32.6% | -$3470.00 |
| Net loss per common share, diluted | -$3680.00+38.6% | -$5990.00-13.7% | -$5270.00-14.6% | -$4600.00-32.6% | -$3470.00 |
| Weighted average common shares outstanding, basic | 49.75B+3.8% | 47.91B+5.5% | 45.43B+11.7% | 40.66B+8.1% | 37.62B |
| Weighted average common shares outstanding, diluted | 49.75B+3.8% | 47.91B+5.5% | 45.43B+11.7% | 40.66B+8.1% | 37.62B |
| Product Sales | |||||
| License Revenue | |||||
| Royalty and Milestone Revenue | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.